Methylphenidate (MP) is a stimulant used to treat ADHD that works by blocking the dopamine transporter. This causes increased tonic dopamine levels in the striatum. In cocaine addicts, MP activated the orbitofrontal cortex and medial prefrontal cortex, but not in controls. This suggests MP may increase craving and drug-seeking behavior by dysregulating dopamine signaling in brain regions involved in reward processing and decision making. A dopaminergic model of drug abuse proposes that blocking the dopamine transporter initially increases dopamine, but prolonged use leads to dopamine deficits that drive further drug use.